The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Do You Get Hungry On Mounjaro?
One of the most common questions about Mounjaro (tirzepatide) is whether you still feel hungry while taking it. The short answer is: most people experience significantly reduced appetite and hunger, though individual experiences vary. Mounjaro works as a dual GIP and GLP-1 receptor agonist, activating two natural hunger-regulating pathways in your body. This dual mechanism is what makes it different from other weight loss injections. However, appetite suppression isn't assured for everyone, and it typically develops gradually as your dose increases. Understanding what to expect can help you prepare for this UK prescription medication's effects on your eating habits.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Mounjaro Affects Hunger and Appetite
Mounjaro reduces hunger through two main mechanisms:
- GLP-1 activation: Signals to your brain that you're full and satisfied, reducing cravings and food-seeking behaviour
- GIP activation: Works alongside GLP-1 to regulate appetite hormones and improve satiety signals
- Gastric emptying: Slows how quickly food leaves your stomach, prolonging the feeling of fullness after meals
In the SURMOUNT-1 clinical trial, participants on Mounjaro reported markedly reduced appetite from around week 2–4 after starting treatment. Most people describe eating significantly smaller portions and feeling satisfied after less food. Some users report that food becomes less appealing or that they forget to eat. However, this effect is dose-dependent — hunger reduction typically increases as you titrate through the dose ranges (2.5 mg → 5 mg → 7.5 mg and beyond).
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
What to Expect: Hunger Levels at Different Stages
During the first 1–2 weeks at the starting dose (2.5 mg), many people notice minimal appetite changes. By weeks 3–4, most experience noticeable hunger reduction. As you progress to higher maintenance doses (5 mg, 7.5 mg, 10 mg, 15 mg), appetite suppression typically becomes more pronounced. Some people find their appetite settles at a certain dose and doesn't increase further, even if they stay on the same injection for months. Others find hunger gradually returns over time, though usually at a lower baseline than before treatment. It's important to remember that Mounjaro works best alongside a reduced-calorie diet and increased physical activity — the medication supports these changes by reducing hunger, but doesn't replace them. Use our free GLP-1 weight loss calculator to explore potential outcomes with Mounjaro, and track your progress with our progress tracker.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Will I feel completely hungry-free on Mounjaro?
Most people experience significantly reduced hunger, but not necessarily zero hunger. You may still feel hungry before meals or at your normal eating times, but portions feel smaller and satisfaction comes faster. Some people do report near-complete appetite suppression, especially at higher doses, but experiences vary. Your GP or prescriber can discuss realistic expectations for your situation.
When does the appetite suppression start on Mounjaro?
Many people notice reduced appetite within 2–4 weeks of starting the 2.5 mg dose. However, some don't notice changes until they reach the 5 mg maintenance dose. Appetite suppression typically increases as your dose increases during titration (the gradual dose-stepping process). If you're not experiencing noticeable appetite changes after 4 weeks, discuss this with your prescriber.
Can hunger come back while on Mounjaro?
Yes, in some cases. Over time (weeks to months), some people find their appetite gradually returns to baseline or higher, even while continuing the same dose. This is called tachyphylaxis. If this happens, your prescriber may increase your dose or discuss alternative options. Regular monitoring helps catch this early.
What's the difference between Mounjaro and Wegovy for hunger?
Mounjaro (tirzepatide) is a dual GIP and GLP-1 agonist, while Wegovy (semaglutide) is a GLP-1 agonist only. Clinical trials suggest Mounjaro may produce slightly greater appetite suppression on average, but individual responses vary significantly. Some people find Wegovy more effective. Only a prescriber can determine which is appropriate for you based on your health profile.
Should I feel hungry if Mounjaro isn't working?
If you're experiencing no change in appetite after 4 weeks at your current dose, contact your prescriber. This could mean the dose needs adjusting, or Mounjaro may not be the best option for you. Your prescriber will assess whether to increase your dose, switch to a different medication, or explore other approaches. Don't adjust or stop treatment without medical guidance.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.